The peroxisomal transporter ABCD3 plays a major role in dicarboxylic fatty acid metabolism
暂无分享,去创建一个
S. Friedman | S. Houten | M. Puchowicz | Chunli Yu | Pablo Ranea-Robles | D. Bhattacharya | B. Stauffer | Hongjie Chen | Brandon Stauffer
[1] C. Argmann,et al. Deficiency of peroxisomal L-bifunctional protein (EHHADH) causes male-specific kidney hypertrophy and proximal tubular injury in mice , 2021, bioRxiv.
[2] S. Friedman,et al. Murine deficiency of peroxisomal l-bifunctional protein (EHHADH) causes medium-chain 3-hydroxydicarboxylic aciduria and perturbs hepatic cholesterol homeostasis , 2021, Cellular and Molecular Life Sciences.
[3] H. Waterham,et al. Peroxisomal Metabolite and Cofactor Transport in Humans , 2021, Frontiers in Cell and Developmental Biology.
[4] F. Vaz,et al. Slc22a5 haploinsufficiency does not aggravate the phenotype of the long‐chain acyl‐CoA dehydrogenase KO mouse , 2019, Journal of inherited metabolic disease.
[5] C. Argmann,et al. Peroxisomes can oxidize medium‐ and long‐chain fatty acids through a pathway involving ABCD3 and HSD17B4 , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] David S. Wishart,et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis , 2018, Nucleic Acids Res..
[7] Michael F. Wangler,et al. A metabolomic map of Zellweger spectrum disorders reveals novel disease biomarkers , 2018, Genetics in Medicine.
[8] Steve D. M. Brown,et al. High-throughput discovery of novel developmental phenotypes , 2017 .
[9] M. Baes,et al. Hepatic dysfunction in peroxisomal disorders. , 2016, Biochimica et biophysica acta.
[10] Marc Engelen,et al. Zellweger spectrum disorders: clinical overview and management approach , 2015, Orphanet Journal of Rare Diseases.
[11] J. Kelleher,et al. Compartmentation of Metabolism of the C12-, C9-, and C5-n-dicarboxylates in Rat Liver, Investigated by Mass Isotopomer Analysis , 2015, The Journal of Biological Chemistry.
[12] Adam D. Kennedy,et al. Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism , 2015, Journal of Inherited Metabolic Disease.
[13] A. Moser,et al. A novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3. , 2015, Human molecular genetics.
[14] H. Waterham,et al. A role for the human peroxisomal half-transporter ABCD3 in the oxidation of dicarboxylic acids. , 2014, Biochimica et biophysica acta.
[15] W. Wahli,et al. The peroxisomal enzyme L-PBE is required to prevent the dietary toxicity of medium-chain fatty acids. , 2013, Cell reports.
[16] R. Wanders,et al. Characterization of D-3-hydroxybutyrylcarnitine (ketocarnitine): an identified ketosis-induced metabolite. , 2012, Metabolism: clinical and experimental.
[17] C. Argmann,et al. Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids , 2012, Journal of Lipid Research.
[18] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[19] F. Theodoulou,et al. Mammalian peroxisomal ABC transporters: from endogenous substrates to pathology and clinical significance , 2011, British journal of pharmacology.
[20] P. Carmeliet,et al. Carbohydrate Metabolism Is Perturbed in Peroxisome-deficient Hepatocytes Due to Mitochondrial Dysfunction, AMP-activated Protein Kinase (AMPK) Activation, and Peroxisome Proliferator-activated Receptor γ Coactivator 1α (PGC-1α) Suppression* , 2011, The Journal of Biological Chemistry.
[21] J. Swinnen,et al. Hepatosteatosis in peroxisome deficient liver despite increased β-oxidation capacity and impaired lipogenesis. , 2011, Biochimie.
[22] Jianguo Xia,et al. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst , 2011, Nature Protocols.
[23] Stephen F Previs,et al. Triglyceride Synthesis in Epididymal Adipose Tissue , 2009, Journal of Biological Chemistry.
[24] E. Ver Loren van Themaat,et al. Coordinate induction of PPAR alpha and SREBP2 in multifunctional protein 2 deficient mice. , 2008, Biochimica et biophysica acta.
[25] R. Wanders,et al. Characterization of L-aminocarnitine, an inhibitor of fatty acid oxidation. , 2008, Molecular genetics and metabolism.
[26] A. Moser,et al. Clinical, biochemical, and mutational spectrum of peroxisomal acyl–coenzyme A oxidase deficiency , 2007, Human mutation.
[27] J. Reddy,et al. Beta-oxidation in hepatocyte cultures from mice with peroxisomal gene knockouts. , 2007, Biochemical and biophysical research communications.
[28] C. Hoppel,et al. Probing peroxisomal β-oxidation and the labelling of acetyl-CoA proxies with [1-13C]octanoate and [3-13C]octanoate in the perfused rat liver , 2005 .
[29] S. Ferdinandusse,et al. Developmental Changes of Bile Acid Composition and Conjugation in L- and D-Bifunctional Protein Single and Double Knockout Mice* , 2005, Journal of Biological Chemistry.
[30] Ilse Vanhorebeek,et al. Absence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalities , 2005, Hepatology.
[31] R. Wanders,et al. Characterization of carnitine and fatty acid metabolism in the long-chain acyl-CoA dehydrogenase-deficient mouse. , 2005, The Biochemical journal.
[32] S. Ferdinandusse,et al. Identification of the peroxisomal β-oxidation enzymes involved in the degradation of long-chain dicarboxylic acids Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.M300512-JLR200 , 2004, Journal of Lipid Research.
[33] Ronald J A Wanders,et al. Phosphomevalonate kinase is a cytosolic protein in humans Published, JLR Papers in Press, January 16, 2004. DOI 10.1194/jlr.M300373-JLR200 , 2004, Journal of Lipid Research.
[34] David Millington,et al. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance , 2004, Nature Medicine.
[35] Ronald J A Wanders,et al. Mevalonate kinase is a cytosolic enzyme in humans , 2004, Journal of Cell Science.
[36] P. Vreken,et al. Rapid analysis of conjugated bile acids in plasma using electrospray tandem mass spectrometry: Application for selective screening of peroxisomal disorders , 1999, Journal of Inherited Metabolic Disease.
[37] V. Chandramouli,et al. Influence of diet on the modeling of adipose tissue triglycerides during growth. , 2003, American journal of physiology. Endocrinology and metabolism.
[38] R. Wanders,et al. Characteristic Acylcarnitine Profiles in Inherited Defects of Peroxisome Biogenesis: A Novel Tool for Screening Diagnosis Using Tandem Mass Spectrometry , 2003, Pediatric Research.
[39] B. Poll-The,et al. Phytanic and pristanic acid are naturally occuring ligands. , 2003, Advances in experimental medicine and biology.
[40] F. Wouters,et al. Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. , 1998, Genes & development.
[41] J. Reddy,et al. Hepatocellular and Hepatic Peroxisomal Alterations in Mice with a Disrupted Peroxisomal Fatty Acyl-coenzyme A Oxidase Gene* , 1996, The Journal of Biological Chemistry.
[42] M. Pourfarzam,et al. Skeletal muscle mitochondrial β-oxidation of dicarboxylates , 1993 .
[43] M. Pourfarzam,et al. Skeletal muscle mitochondrial beta-oxidation of dicarboxylates. , 1993, Biochimica et biophysica acta.
[44] K. Tserng,et al. Metabolic conversion of dicarboxylic acids to succinate in rat liver homogenates. A stable isotope tracer study. , 1991, The Journal of biological chemistry.
[45] M. Pourfarzam,et al. Products and intermediates of the beta-oxidation of [U-14C]hexadecanedionoyl-mono-CoA by rat liver peroxisomes and mitochondria. , 1991, The Biochemical journal.
[46] T. Hashimoto,et al. The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily. , 1990, The Journal of biological chemistry.
[47] F. Leighton,et al. Free acetate production by rat hepatocytes during peroxisomal fatty acid and dicarboxylic acid oxidation. , 1989, The Journal of biological chemistry.
[48] H. Moser,et al. Peroxisomal L-Pipecolic Acid Oxidation Is Deficient in Liver from Zellweger Syndrome Patients , 1989, Pediatric Research.
[49] T. Watanabe,et al. Compartmentation of dicarboxylic acid beta-oxidation in rat liver: importance of peroxisomes in the metabolism of dicarboxylic acids. , 1989, Biochimica et biophysica acta.
[50] F. Gonzalez,et al. Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid omega-hydroxylase (cytochrome P-450LA omega). Identification of a new cytochrome P-450 gene family. , 1987, The Journal of biological chemistry.
[51] S. Kolvraa,et al. In vitro studies on the oxidation of medium-chain dicarboxylic acids in rat liver. , 1986, Biochimica et biophysica acta.
[52] P. Bougnères,et al. Medium- and Long-Chain Dicarboxylic Aciduria in Patients with Zellweger Syndrome and Neonatal Adrenoleukodystrophy , 1986, Pediatric Research.
[53] G. Getz,et al. Effect of Reye's syndrome serum on isolated chinchilla liver mitochondria. , 1985, The Journal of clinical investigation.
[54] S. Passi,et al. Antimitochondrial effect of saturated medium chain length (C8-C13) dicarboxylic acids. , 1984, Biochemical pharmacology.
[55] T. P. Krishnakantha,et al. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate , 1975, Science.
[56] J. E. Pettersen. In vitro studies on the metabolism of hexadecanedioic acid and its mono-L-carnitine ester. , 1973, Biochimica et biophysica acta.
[57] K. Bloch,et al. OMEGA-OXIDATION OF LONG CHAIN FATTY ACIDS IN RAT LIVER. , 1964, The Journal of biological chemistry.